The inactivation of extracellularly administered amino acids in the feline spinal cord.
D000200:Action Potentials; D000409:Alanine / Q000494:pharmacology; D000596:Amino Acids / Q000037:antagonists & inhibitors* / Q000378:metabolism; D000613:Aminobutyrates / Q000378:metabolism / Q000494:pharmacology; D000818:Animals; D001224:Aspartic Acid / Q000378:metabolism; D001555:Benzene Derivatives / Q000494:pharmacology; D001565:Benzoates / Q000494:pharmacology; D001692:Biological Transport; D001921:Brain / Q000378:metabolism; D002415:Cats; D003864:Depression, Chemical; D004357:Drug Synergism; D005998:Glycine / Q000378:metabolism / Q000494:pharmacology; D006834:Hydrazines / Q000494:pharmacology; D007395:Interneurons / Q000187:drug effects; D008239:Lysine / Q000378:metabolism; D008628:Mercury / Q000494:pharmacology; D009046:Motor Neurons / Q000502:physiology; D009474:Neurons / Q000187:drug effects; D011422:Propionates / Q000494:pharmacology; D051381:Rats; D013116:Spinal Cord / Q000187:drug effects / Q000378:metabolism*; D013268:Stimulation, Chemical; D013451:Sulfonic Acids / Q000494:pharmacology; D013569:Synapses; D013882:Thiosemicarbazones / Q000494:pharmacology
D000596:Amino Acids; D000613:Aminobutyrates; D001555:Benzene Derivatives; D001565:Benzoates; D006834:Hydrazines; D011422:Propionates; D013451:Sulfonic Acids; D013882:Thiosemicarbazones; D001224:Aspartic Acid; D008628:Mercury; D008239:Lysine; D000409:Alanine; D005998:Glycine